0001600132-18-000073.txt : 20180607
0001600132-18-000073.hdr.sgml : 20180607
20180607165434
ACCESSION NUMBER: 0001600132-18-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180605
FILED AS OF DATE: 20180607
DATE AS OF CHANGE: 20180607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENNETT MATTHEW
CENTRAL INDEX KEY: 0001267642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 18887076
MAIL ADDRESS:
STREET 1: 227 WASHINGTON ST
STREET 2: STE 200
CITY: CONSHONHOEKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_152840485873445.xml
FORM 4
X0306
4
2018-06-05
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001267642
BENNETT MATTHEW
C/O NEW MOUNTAIN CAPITAL, L.L.C.
787 SEVENTH AVENUE, 49TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Stock Option (right to buy)
2.27
2018-06-05
4
A
0
38216
2.27
A
2019-06-05
2028-06-04
Common Stock
38216.0
38216
D
Matthew Bennett
2018-06-05